Guillermo Suñé

Hospital Clínic de Barcelona — Spain

Medicine · Health Sciences

13h-index962citations27works2.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(14), Immune Cell Function and Interaction(11), Immunotherapy and Immune Responses(7), Viral Infectious Diseases and Gene Expression in Insects(5), Virus-based gene therapy research(3)

Publications27 total

CRISPR/Cas9 Multi-Editing Enhances CAR NK Cells Therapeutic Potential Against Multiple Myeloma
Blood·2024· 5 citedOpen Access
OA-02 Multiplex CRISPR/Cas9 Genome Editing of Cord Blood-derived CAR NK Cells to Improve Their Persistence and Antitumoral Potential Against Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2024
OA-02 α-NKG2A blockade overcomes multiple myeloma resistance to BCMA and NKG2D CAR-NKAE cells
Clinical Lymphoma Myeloma & Leukemia·2023
S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY
HemaSphere·2023· 2 citedOpen Access
P-015: Comprehensive comparison of allogenic CAR NK cells for MM treatment
Clinical Lymphoma Myeloma & Leukemia·2022
P-007: Exploring a safety switch in NKG2D and BCMA CAR NK-92MI immunotherapy
Clinical Lymphoma Myeloma & Leukemia·2021· 3 cited
Cell Banking of HEK293T cell line for clinical-grade lentiviral particles manufacturing
Translational Medicine Communications·2020· 4 citedOpen Access
Cell Banking of HEK293T cell line for clinical-grade lentiviral particles manufacturing
Research Square (Research Square)·2020Open Access
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies
Molecular Therapy·2020· 151 citedOpen Access
Cell Banking of HEK293T Cell Line for Clinical-Grade Lentiviral Particles Manufacturing
Research Square (Research Square)·2020Open Access
Cell Banking of HEK293T Cell Line for Clinical-Grade Lentiviral Particles Manufacturing
2020Open Access
Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial
Frontiers in Immunology·2020· 132 citedOpen Access
Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma
Haematologica·2020· 41 citedOpen Access
Extracellular NK histones promote immune cell anti-tumor activity by inducing cell clusters through binding to CD138 receptor
Journal for ImmunoTherapy of Cancer·2019· 17 citedOpen Access
Exploring NKG2D and BCMA-CAR NK-92 for Adoptive Cellular Therapy to Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2019· 13 cited
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions
Molecular Therapy — Methods & Clinical Development·2018· 122 citedOpen Access
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma
The Journal of Immunology·2018· 28 cited
Natural Killer Cells: Angels and Devils for Immunotherapy
International Journal of Molecular Sciences·2017· 69 citedOpen Access
Natural Killer Cells Transfer Antimicrobial and Antitumoral Histone H2AZ to Kill Multiple Myeloma Cells Contributing to Transmissible Cytotoxicity
Blood·2016· 1 cited
Cell-Cell Communication Between Multiple Myeloma (MM) Cells and Cord Blood Derived NK Cells (CB-NK) Regulates Both Tumor Cell Death and Tumor Cell Survival
Blood·2015· 1 cited
page 1 of 2Next →

Frequent Co-authors

Beatriz Martín-Antonio(14), María Castellà(10), Álvaro Urbano-Ispizúa(10), Manel Juan(8), Josep M. Canals(7), Julio Delgado(7), Jessica Encinas(7), Almudena García-Ortiz(7), Alejandra Leivas(7), Paula Rı́o(7), Antonio Valeri(7), Unai Perpiñá(6), Anna Boronat(6), Lorena Pérez-Amill(6), Joaquín Martínez‐López(6), Eva Castellano(6), Raquel Martín‐Ibáñez(5), Laura Ugalde(5), María‐Teresa Cedena(5), Chris Jopling(4)